New vaccine aims to broaden protection against Pneumonia-Causing bacteria
NCT ID NCT06678620
Summary
This study is testing a new vaccine designed to protect against 24 strains of pneumococcal bacteria, which can cause pneumonia and other serious infections. It will involve 992 healthy Chinese adults aged 18 and older to see how safe the vaccine is and how well it triggers an immune response. The trial compares three versions of the new vaccine against an existing 23-strain vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pizhou Center for Disease Control and Prevention
Pizhou, Jiangsu, China
-
Xuzhou Center for Disease Control and Prevention
Xuzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.